--- title: "NOVONIX (NASDAQ:NVX) Shares Down 1.3% - Here's Why" type: "News" locale: "en" url: "https://longbridge.com/en/news/293088085.md" description: "NOVONIX (NASDAQ:NVX) shares fell 1.3% to $0.4134, with trading volume down 55%. Weiss Ratings reaffirmed a 'sell' rating, and the consensus remains 'Sell'. Key financial metrics include a quick ratio of 1.04 and debt-to-equity of 0.23. Institutional activity saw Jane Street Group, XTX Topco Ltd, SmartHarvest Portfolios LLC, Citadel Advisors LLC, and Quadrature Capital Ltd adjust their stakes in Q4 and Q1." datetime: "2026-07-18T05:00:36.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/293088085.md) - [en](https://longbridge.com/en/news/293088085.md) - [zh-HK](https://longbridge.com/zh-HK/news/293088085.md) --- # NOVONIX (NASDAQ:NVX) Shares Down 1.3% - Here's Why NOVONIX Limited Sponsored ADR (NASDAQ:NVX - Get Free Report)'s stock price was down 1.3% during mid-day trading on Friday . The stock traded as low as $0.3998 and last traded at $0.4134. 110,942 shares were traded during trading, a decline of 55% from the average session volume of 247,612 shares. The stock had previously closed at $0.4187. ## Analysts Set New Price Targets Separately, Weiss Ratings reaffirmed a "sell (e+)" rating on shares of NOVONIX in a research report on Tuesday, April 21st. One analyst has rated the stock with a Sell rating, According to data from MarketBeat, NOVONIX has a consensus rating of "Sell". **Check Out Our Latest Analysis on NVX** ## NOVONIX Stock Performance The company has a quick ratio of 1.04, a current ratio of 1.07 and a debt-to-equity ratio of 0.23. The business has a fifty day moving average price of $0.57 and a two-hundred day moving average price of $0.79. ## Institutional Inflows and Outflows A number of institutional investors and hedge funds have recently added to or reduced their stakes in NVX. Jane Street Group LLC acquired a new position in NOVONIX in the 4th quarter valued at approximately $1,063,000. XTX Topco Ltd boosted its stake in shares of NOVONIX by 388.0% during the 4th quarter. XTX Topco Ltd now owns 270,796 shares of the company's stock valued at $274,000 after buying an additional 215,305 shares during the period. SmartHarvest Portfolios LLC acquired a new stake in shares of NOVONIX during the 1st quarter valued at $100,000. Citadel Advisors LLC grew its holdings in shares of NOVONIX by 964.1% during the 3rd quarter. Citadel Advisors LLC now owns 109,374 shares of the company's stock valued at $140,000 after acquiring an additional 99,095 shares in the last quarter. Finally, Quadrature Capital Ltd purchased a new position in shares of NOVONIX during the 4th quarter valued at $97,000. 0.06% of the stock is owned by hedge funds and other institutional investors. ## About NOVONIX (Get Free Report) NOVONIX, trading under the NASDAQ ticker NVX, is a technology-driven company specializing in the development and production of advanced materials and testing solutions for the lithium-ion battery industry. The company's primary focus lies in supplying high-purity synthetic graphite anode materials and delivering comprehensive battery testing services to original equipment manufacturers (OEMs), research institutions, and battery producers worldwide. NOVONIX operates through two core divisions: NOVONIX Materials & Technology, which produces battery-grade graphite, and NOVONIX Battery Testing Solutions, which offers hardware and software platforms designed to accelerate battery research and development. The Materials & Technology business segment manufactures spherical synthetic graphite anode products that meet rigorous industry standards for performance, consistency, and scalability. ## Recommended Stories - Five stocks we like better than NOVONIX - AST SpaceMobile Stock Sinks as SpaceX Fallout Rattles Space Sector - Aehr Test Systems Stock Soars on Earnings, Eyes Over 150% Revenue Growth - TSMC Just Gave AI Chip Bulls Another Reason to Stay Confident - GE Aerospace Faces a Prove-It Moment in Q2 Earnings _This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com._ ## Should You Invest $1,000 in NOVONIX Right Now? Before you consider NOVONIX, you'll want to hear this. MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and NOVONIX wasn't on the list. While NOVONIX currently has a Sell rating among analysts, top-rated analysts believe these five stocks are better buys. View The Five Stocks Here ### Related Stocks - [NVNXF.US](https://longbridge.com/en/quote/NVNXF.US.md) - [NVX.US](https://longbridge.com/en/quote/NVX.US.md) - [NVX.AU](https://longbridge.com/en/quote/NVX.AU.md) - [ASTS.US](https://longbridge.com/en/quote/ASTS.US.md) - [SPCX.US](https://longbridge.com/en/quote/SPCX.US.md) - [AEHR.US](https://longbridge.com/en/quote/AEHR.US.md) - [TSM.US](https://longbridge.com/en/quote/TSM.US.md) - [GE.US](https://longbridge.com/en/quote/GE.US.md) ## Related News & Research - [NOVONIX Stock Scheduled to Reverse Split on Thursday, August 27th (NASDAQ:NVX)](https://longbridge.com/en/news/295992514.md) - [Here's why Middleby stock is an opportunity after this week's drop](https://longbridge.com/en/news/296003309.md) - [First Trust Small Cap Growth AlphaDEX Fund (NASDAQ:FYC) Short Interest Down 61.4% in July](https://longbridge.com/en/news/295936123.md) - [4D Molecular Therapeutics (NASDAQ:FDMT) Announces Quarterly Earnings Results](https://longbridge.com/en/news/295844395.md) - [Nasdaq Confirmed AGM Group Holdings Inc. Complies with The Nasdaq Listing Rules | AGMH Stock News](https://longbridge.com/en/news/295669211.md)